Last reviewed · How we verify
autologous human Schwann cells — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
autologous human Schwann cells (autologous human Schwann cells) — W. Dalton Dietrich.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| autologous human Schwann cells TARGET | autologous human Schwann cells | W. Dalton Dietrich | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- autologous human Schwann cells CI watch — RSS
- autologous human Schwann cells CI watch — Atom
- autologous human Schwann cells CI watch — JSON
- autologous human Schwann cells alone — RSS
Cite this brief
Drug Landscape (2026). autologous human Schwann cells — Competitive Intelligence Brief. https://druglandscape.com/ci/autologous-human-schwann-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab